Back to Authors

Bloom, Patricia

Mayo Clinic

Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Citations 1

The Pros & Cons of Measuring Plasma Ammonia in the Management of Patients With Cirrhosis: An ISHEN Debate

Liver International | October 23, 2026 | Volume: 46 | Issue: 11 | Pages: No page available

10.1111/liv.70904 | PMID 42922100

ABSTRACT Ammonia is a nitrogenous molecule which is primarily generated in the gastrointestinal tract. The neurotoxicity of ammonia plays a critical role in the liver's regulation of circulating ammonia levels. In liver disease, an increase in blood ammonia has been long implicated in the pathogenesis of hepatic encephalopathy (HE), a neurological complication of liver disease. However, the clinical value of measuring plasma ammonia in patients with cirrhosis remains controversial. This dilemma was the subject of a debate held at the International Society of Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) meeting in St‐Paulin, Québec, Canada in October 2025. This review illustrates the pros & cons of measuring plasma ammonia in the management of patients with cirrhosis.